Theragen ETEX Bio Institute said it signed a service contract with the Korea Centers for Disease Control and Prevention (KCDC) to analyze alcohol metabolism-related genes and its disease correlation, last Saturday.
Under the 280 million-won ($262,800) contract, Theragen will conduct systematic gene mutation distribution and disease correlation analysis of alcohol metabolism enzymes in Koreans for a year. East Asian people have various genetic variants that are less effective in metabolizing alcohol than Westerners.
In Korea, alcohol consumption per capita continues to grow, while the nation’s drinking culture exposes people to an environment where drinking is acceptable. Such circumstances have raised the risk of people, who are born with weak genes for metabolizing alcohol, of suffering from various diseases such as esophageal and stomach cancer.
“Through this research, the company expects to search the distribution of genetic susceptibility to alcohol among Koreans, while contributing to the government's policy in effectively managing the consumption of alcohol,” said Hong Kyung-won, a Theragen ETEX manager responsible for leading the research.
<© Korea Biomedical Review, All rights reserved.>